Valion Bio issues $250K in Series B Preferred and warrants to 3i, LP

Valion Bio, Inc.

Issued 250 Series B Preferred shares at $1,000 each and a warrant for 156,026 common shares at $0.61628 per share.
Aggregate purchase price of $250,000 received from 3i, LP.
Securities issued under Section 4(a)(2) and Rule 506(b) exemption from registration.
Purchase agreement originally with an investor, assigned to 3i, LP on December 9, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.